These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11170626)
1. 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor. Harada H; Asano O; Hoshino Y; Yoshikawa S; Matsukura M; Kabasawa Y; Niijima J; Kotake Y; Watanabe N; Kawata T; Inoue T; Horizoe T; Yasuda N; Minami H; Nagata K; Murakami M; Nagaoka J; Kobayashi S; Tanaka I; Abe S J Med Chem; 2001 Jan; 44(2):170-9. PubMed ID: 11170626 [TBL] [Abstract][Full Text] [Related]
2. 2-Alkynyl-8-aryladenines possessing an amide moiety: their synthesis and structure-activity relationships of effects on hepatic glucose production induced via agonism of the A(2B) adenosine receptor. Harada H; Asano O; Kawata T; Inoue T; Horizoe T; Yasuda N; Nagata K; Murakami M; Nagaoka J; Kobayashi S; Tanaka I; Abe S Bioorg Med Chem; 2001 Oct; 9(10):2709-26. PubMed ID: 11557358 [TBL] [Abstract][Full Text] [Related]
3. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands. Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910 [TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry and pharmacology of A2B adenosine receptors. Volpini R; Costanzi S; Vittori S; Cristalli G; Klotz KN Curr Top Med Chem; 2003; 3(4):427-43. PubMed ID: 12570760 [TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes. Yasuda N; Inoue T; Horizoe T; Nagata K; Minami H; Kawata T; Hoshino Y; Harada H; Yoshikawa S; Asano O; Nagaoka J; Murakami M; Abe S; Kobayashi S; Tanaka I Eur J Pharmacol; 2003 Jan; 459(2-3):159-66. PubMed ID: 12524141 [TBL] [Abstract][Full Text] [Related]
7. 9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities. Klotz KN; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):629-34. PubMed ID: 12734636 [TBL] [Abstract][Full Text] [Related]
8. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Linden J; Thai T; Figler H; Jin X; Robeva AS Mol Pharmacol; 1999 Oct; 56(4):705-13. PubMed ID: 10496952 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor. Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists. Baraldi PG; Cacciari B; Moro S; Spalluto G; Pastorin G; Da Ros T; Klotz KN; Varani K; Gessi S; Borea PA J Med Chem; 2002 Feb; 45(4):770-80. PubMed ID: 11831890 [TBL] [Abstract][Full Text] [Related]
11. Adenosine A1 receptors mediate chronic ethanol-induced increases in receptor-stimulated cyclic AMP in cultured hepatocytes. Nagy LE; DeSilva SE Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):205-10. PubMed ID: 7998934 [TBL] [Abstract][Full Text] [Related]
12. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286 [TBL] [Abstract][Full Text] [Related]
13. "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists. Perreira M; Jiang JK; Klutz AM; Gao ZG; Shainberg A; Lu C; Thomas CJ; Jacobson KA J Med Chem; 2005 Jul; 48(15):4910-8. PubMed ID: 16033270 [TBL] [Abstract][Full Text] [Related]
14. A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Dubey RK; Gillespie DG; Zacharia LC; Mi Z; Jackson EK Hypertension; 2001 Feb; 37(2 Pt 2):716-21. PubMed ID: 11230362 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332 [TBL] [Abstract][Full Text] [Related]
17. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. Kim YC; Ji X; Melman N; Linden J; Jacobson KA J Med Chem; 2000 Mar; 43(6):1165-72. PubMed ID: 10737749 [TBL] [Abstract][Full Text] [Related]
18. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Schulte G; Fredholm BB Mol Pharmacol; 2000 Sep; 58(3):477-82. PubMed ID: 10953039 [TBL] [Abstract][Full Text] [Related]
19. New substituted 9-alkylpurines as adenosine receptor ligands. Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466 [TBL] [Abstract][Full Text] [Related]
20. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary. Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]